Audrey Tracey, MD
Family Medicine · Leominster, MANPI 1558329433
Payments from drug & device makers
Across 54 payments — averaging $24.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$520
- Lilly USA, LLC$144
- Pfizer$99
- Teva Pharmaceuticals USA, Inc.$76
- AbbVie$71
- Novo Nordisk$65
- plus $324 from 11 others
What the payments were for
- Food & beverage$1,10985%
- Education$19015%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 16 | $520 |
| Lilly USA, LLC | 6 | $144 |
| Pfizer | 5 | $99 |
| Teva Pharmaceuticals USA, Inc. | 3 | $76 |
| AbbVie | 3 | $71 |
| Novo Nordisk | 4 | $65 |
| GSK | 3 | $64 |
| Ironshore Pharmaceuticals Inc. | 2 | $43 |
| Merck | 3 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Biogen | 1 | $27 |
| Johnson & Johnson | 1 | $25 |
| Indivior Inc. | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
How this compares
$1,299 in reported general payments places this provider in the 85th percentile of 1,049 family medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 81 | $1,586 |
| Simvastatin | 90 | $1,093 |
| Levothyroxine Sodium | 82 | $1,075 |
| Rosuvastatin Calcium | 28 | $1,007 |
| Lisinopril | 95 | $756 |
| Gabapentin | 21 | $680 |
| Omeprazole | 37 | $560 |
| Metoprolol Succinate | 24 | $545 |
| Trazodone Hcl | 31 | $511 |
| Losartan Potassium | 29 | $410 |
| Amlodipine Besylate | 43 | $409 |
| Metformin Hcl ErMetformin Hcl | 25 | $403 |
| Carvedilol | 13 | $251 |
| Metoprolol Tartrate | 19 | $242 |
| Hydrochlorothiazide | 51 | $231 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Leominster
- Robert BeckWestford$2.1M
- Katherine Gergen BarnettBoston$226K
- Peter O'DwyerBoston$163K
- Kelly LannuttiWeymouth$122K
- Larry CulpepperBoston$109K
- Jennifer WeylerWorcester$105K
- Megan McCoyFramingham$75K
- Kristina GraceyWorcester$73K
- Suzanne MitchellBoston$69K
- John GrievesonLowell$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.